<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">University of Belgrade</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Belgrade, Serbia</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Public Research University</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.bg.ac.rs" target="_blank">https://www.bg.ac.rs</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Alzheimer's Disease, Parkinson's Disease, Neuroinflammation, Neurotoxicity</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1808</td>
</tr>
</table>
The University of Belgrade (Univerzitet u Beogradu), founded in 1808, stands as the oldest and largest university in Serbia and one of the oldest higher education institutions in the Balkans. Located in the capital city of Belgrade on the banks of the Sava and Danube rivers, the university has evolved from its origins as the "Great School" (Velika Skola) into a comprehensive research university with over 100,000 students across 31 faculties. The university's contributions to neuroscience and neurodegenerative disease research have grown substantially in recent decades, particularly through the Institute for Biological Research "Siniša Stanković" (IBISS), which serves as the premier neuroscience research institute in Serbia[@unibelgrade][@ibiss].
<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">University of Belgrade</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Belgrade, Serbia</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Public Research University</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.bg.ac.rs" target="_blank">https://www.bg.ac.rs</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Alzheimer's Disease, Parkinson's Disease, Neuroinflammation, Neurotoxicity</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1808</td>
</tr>
</table>
The University of Belgrade (Univerzitet u Beogradu), founded in 1808, stands as the oldest and largest university in Serbia and one of the oldest higher education institutions in the Balkans. Located in the capital city of Belgrade on the banks of the Sava and Danube rivers, the university has evolved from its origins as the "Great School" (Velika Skola) into a comprehensive research university with over 100,000 students across 31 faculties. The university's contributions to neuroscience and neurodegenerative disease research have grown substantially in recent decades, particularly through the Institute for Biological Research "Siniša Stanković" (IBISS), which serves as the premier neuroscience research institute in Serbia[@unibelgrade][@ibiss].
The university's location in southeastern Europe provides unique research opportunities, including studies on environmental neurotoxicants, population genetics of neurodegenerative diseases, and regional health disparities. Serbia's position as a bridge between Eastern and Western Europe facilitates collaborative research with institutions across the continent. The university maintains active partnerships with European Union research consortia, contributing to major initiatives addressing Alzheimer's disease, Parkinson's disease, and related conditions[@sanu].
The University of Belgrade traces its origins to 1808, when the "Great School" was established in the Principality of Serbia during the First Serbian Uprising against Ottoman rule. This early institution, while modest in scope, represented a pioneering effort to establish higher education in the Serbian language. The school's evolution through the turbulent 19th century reflected the broader political and social transformations of the region.
The formal establishment of the university came in 1905, when the Great School was reorganized into the University of Belgrade with four initial faculties: Philosophy, Law, Medicine, and Technical Sciences. This transformation established the institutional framework that would guide the university's development through the 20th century and into the present day.
The 20th century brought both challenges and growth to the university. World wars, political upheaval, and the socialist period created significant disruptions, but the university maintained its commitment to education and research. The post-World War II period saw substantial expansion, with new faculties established and research programs developed across disciplines.
The Institute for Biological Research "Siniša Stanković" was established as a major research facility, bringing together biologists and medical scientists in a collaborative environment. The institute's focus on molecular biology and neuroscience laid the groundwork for the research programs that would later address neurodegenerative diseases.
The past three decades have seen dramatic transformation as Serbia transitioned from socialist governance and the university embraced international collaboration. The Institute for Biological Research has expanded its neuroscience programs, contributing to international research consortia and training the next generation of Serbian neuroscientists[@ibiss].
The University of Belgrade maintains substantial research programs on Parkinson's disease, reflecting both the disease's prevalence in Serbia and the expertise of the research community[@pubmed_parkinson].
Dopaminergic Neuron Biology
Investigators study the biology of dopaminergic neurons in the substantia nigra pars compacta, the population specifically lost in Parkinson's disease. Research examines mechanisms of neuronal vulnerability, including mitochondrial dysfunction, oxidative stress, and protein aggregation. Studies on neurotrophic factors explore approaches to protect or regenerate dopaminergic neurons.
Clinical Studies
Clinical researchers conduct observational studies on Parkinson's disease patients, examining disease progression patterns, treatment responses, and quality of life outcomes. Research examines motor complications including fluctuations and dyskinesias, as well as non-motor symptoms including cognitive impairment, sleep disorders, and autonomic dysfunction.
Research programs address Alzheimer's disease and other dementias, contributing to understanding of disease mechanisms and developing diagnostic and therapeutic approaches[@pubmed_alzheimers].
Amyloid and Tau Research
Investigators study amyloid-beta metabolism and tau protein pathology, the core pathological features of Alzheimer's disease. Research examines proteolytic processing of the amyloid precursor protein, aggregation mechanisms, and the relationship between pathology and clinical symptoms.
Biomarker Development
Researchers contribute to biomarker development for Alzheimer's disease diagnosis and progression monitoring[@pubmed_biomarkers]. Studies examine cerebrospinal fluid biomarkers, exploring whether these markers can improve diagnostic accuracy in clinical practice.
The university has developed particular expertise in research on neuroinflammation as a contributor to neurodegenerative disease[@pubmed_neuroinflammation]. Studies examine microglial activation patterns, cytokine release, and the contribution of inflammatory processes to neuronal dysfunction.
The university has unique expertise in research on neurotoxicity, including studies on heavy metals and environmental contaminants that may contribute to neurodegenerative disease risk[@pubmed_heavy_metals].
Heavy Metal Neurotoxicity
Serbia and the broader Balkans region have historical issues with environmental contamination from industrial sources, including heavy metals. Researchers at Belgrade study how exposure to lead, mercury, arsenic, and other neurotoxic metals may contribute to Parkinson's disease and other neurological conditions.
Research on multiple sclerosis represents another significant focus, reflecting the disease's prevalence in Serbia and the region[@pubmed_ms].
Epidemiology and Genetics
Population-based studies examine MS prevalence and incidence in Serbia, contributing to understanding of disease distribution. Research on genetic factors explores whether specific genetic variants influence disease risk or progression in Serbian populations.
The Institute for Biological Research "Siniša Stanković" serves as the premier neuroscience research institution in Serbia[@ibiss]. The institute brings together researchers from multiple disciplines, including molecular biology, cell biology, neuroscience, and pharmacology. Core facilities include animal models, imaging capabilities, and molecular biology equipment.
The School of Medicine integrates clinical care with research programs, providing a framework for translational research on neurodegenerative diseases[@med_bg]. The neurology department provides comprehensive care for patients with Alzheimer's disease, Parkinson's disease, and related conditions, while conducting clinical research.
The University of Belgrade participates in numerous international research collaborations that extend the reach and impact of its research programs. These partnerships enable access to diverse expertise and resources while contributing to global efforts addressing neurodegenerative diseases.
European Union Collaborations
The university participates in Horizon Europe research programs, contributing to multi-institution consortia addressing neurodegeneration. Collaborations with Western European institutions bring advanced research capabilities to Serbian research programs while enabling knowledge transfer.
Regional Balkan Collaborations
Partnerships with universities and research institutions across the Balkans address shared health challenges. These collaborations examine neurodegenerative disease patterns in the region, including environmental risk factors and population genetics.
The School of Medicine provides comprehensive medical training including instruction in neurodegenerative diseases. Medical students receive instruction in neurology and psychiatry, with clinical rotations providing exposure to patients with dementia, Parkinson's disease, and related conditions.
The university offers graduate programs in neuroscience and related fields through multiple faculties. PhD programs provide intensive research training, with dissertation research conducted in laboratories across the university.
The university is expanding clinical research programs, increasing capacity for clinical trials and observational studies. Partnerships with healthcare systems will enable recruitment of larger patient cohorts, improving statistical power and enabling more definitive studies.
Research programs are developing precision medicine approaches for neurodegenerative diseases. Studies examine genetic risk factors in Serbian populations, aiming to identify variants that may influence disease risk or treatment response.